UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054229
Receipt number R000061910
Scientific Title Research on the effect of eating chocolate on feeling of tension
Date of disclosure of the study information 2024/04/26
Last modified on 2024/04/22 15:44:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effect of eating chocolate on feeling of tension

Acronym

Research on the effect of eating chocolate on feeling of tension

Scientific Title

Research on the effect of eating chocolate on feeling of tension

Scientific Title:Acronym

Research on the effect of eating chocolate on feeling of tension

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the impact of eating chocolate on feeling of tension, amount of sweating and heart rate during tension-inducing situations

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

subjective evaluation (tension)

Key secondary outcomes

subjective evaluation (restless state, awareness of others, sense of accomplishment), amount of sweating, heart rate


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Research food are consumed one (standard 4 g) at a time

Interventions/Control_2

Not consuming research food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Healthy males and females from 20 to 64 years of age
(2) Those who fully understand the purpose and content of the research and agree to participate in the research of their own free will
(3) Those who are aware of being easily tense
(4) Those whose amount of sweating and heart rate during the task shows tension-induced changes

Key exclusion criteria

(1) Those who has sweaty hands and measurement difficulties
(2) Those who are judged to be inappropriate as research subjects (subjects) based on their answers to the lifestyle questionnaire
(3) Those who are judged to be unsuitable as subjects based on the answers to the background survey
(4) Those who are suspected of having depression
(5) Those who may develop allergies in relation to research food
(6) Those who are prescribed or regularly use medications that may affect stress
(7) Those who consume health foods such as specified health foods and functional foods related to stress at least one day per week
(8) Those who doesn't like research food
(9) Those who, due to injury or other reasons, have difficulty in measuring amount of sweating or inputting data into a computer
(10) Those who have a disease that requires constant medication (whether external or internal), those who have a disease under treatment (except for dry eye and dental caries treatment), those who have a history of serious disease that required medication
(11) Those whose physical measurements, physical examination values, and clinical examination values before the examination were significantly out of the reference range
(12) Those who work in shifts, work late at night, and have an irregular daily rhythm
(13) Those who plan to go abroad during the study period, or who plan to make a domestic business trip, domestic travel, or return home during the 3 days prior to the Intake Phase I or Intake Phase II test date
(14) Those who participated in other clinical studies, clinical trials, or human trials within one month prior to the start of this study
(15) Those who plan to become pregnant or breastfeed during the study period
(16) Those who are judged as unsuitable for the study by the investigator for other reason

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Higuchi

Organization

Lotte Co., Ltd.

Division name

Central Laboratory

Zip code

336-8601

Address

1-1, Numakage 3-chome, Minami-ku, Saitama-shi, Saitama

TEL

048-837-0162

Email

higuchi_hiroaki@lotte.co.jp


Public contact

Name of contact person

1st name Rio
Middle name
Last name Fujiwara

Organization

EP Mediate Co., Ltd.

Division name

R&D Support Center Foods Department Section 1

Zip code

162-0821

Address

Kagurazaka AK Bldg., 1-8 Tsukudocho, Shinjuku-ku, Tokyo

TEL

070-7079-8488

Homepage URL


Email

fujiwara.rio605@eps.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguro-ku, Tokyo

Tel

03-6452-2712

Email

nakagawa.akiko297@eps.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

メディカルステーションクリニック (Medical station clinic) (東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 04 Month 11 Day

Date of IRB

2024 Year 04 Month 11 Day

Anticipated trial start date

2024 Year 05 Month 07 Day

Last follow-up date

2024 Year 06 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 23 Day

Last modified on

2024 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061910


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name